Shareholders Approve New Chairman & CEO, and ESOP 2026
Cohance Lifesciences Ltd · COHANCE · BSE ·
Shareholders have approved the appointment of Mr. Umang Vohra as the new Chairman and Group CEO. A new Employee Stock Option Plan, 'ESOP 2026', has been approved and will be extended to unlisted subsidiary companies. Approval was also granted for Mr. Vohra's remuneration, which e…